Canada Life’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-63,502
| Closed | -$274K | – | 2216 |
|
|
2023
Q3 | $274K | Sell |
63,502
-47,701
| -43% | -$265K | ﹤0.01% | 1809 |
|
|
2023
Q2 | $735K | Buy |
111,203
+3,508
| +3% | +$22.5K | ﹤0.01% | 1580 |
|
|
2023
Q1 | $731K | Sell |
107,695
-877
| -0.8% | -$6.17K | ﹤0.01% | 1589 |
|
|
2022
Q4 | $804K | Buy |
108,572
+45,699
| +73% | +$445K | ﹤0.01% | 1583 |
|
|
2022
Q3 | $621K | Buy |
62,873
+7,156
| +13% | +$75.6K | ﹤0.01% | 1640 |
|
|
2022
Q2 | $608K | Buy |
55,717
+7,349
| +15% | +$76.1K | ﹤0.01% | 1625 |
|
|
2022
Q1 | $561K | Hold |
48,368
| – | – | ﹤0.01% | 1682 |
|
|
2021
Q4 | $758K | Sell |
48,368
-32
| -0.1% | -$558 | ﹤0.01% | 1610 |
|
|
2021
Q3 | $837K | Hold |
48,400
| – | – | ﹤0.01% | 1585 |
|
|
2021
Q2 | $1.04M | Buy |
48,400
+2,087
| +5% | +$37.3K | ﹤0.01% | 1496 |
|
|
2021
Q1 | $695K | Sell |
46,313
-8,034
| -15% | -$130K | ﹤0.01% | 1650 |
|
|
2020
Q4 | $714K | Sell |
54,347
-5,508
| -9% | -$66.3K | ﹤0.01% | 1643 |
|
|
2020
Q3 | $577K | Sell |
59,855
-6,861
| -10% | -$73.3K | ﹤0.01% | 1635 |
|
|
2020
Q2 | $764K | Sell |
66,716
-3,148
| -5% | -$35.6K | ﹤0.01% | 1547 |
|
|
2020
Q1 | $721K | Buy |
69,864
+2,839
| +4% | +$35.2K | ﹤0.01% | 1456 |
|
|
2019
Q4 | $1.09M | Buy |
+67,025
| New | +$1.01M | ﹤0.01% | 1455 |
|
|
2019
Q3 | – | Sell |
-69,988
| Closed | -$986K | – | 2251 |
|
|
2019
Q2 | $986K | Hold |
69,988
| – | – | ﹤0.01% | 1544 |
|
|
2019
Q1 | $1.29M | Hold |
69,988
| – | – | ﹤0.01% | 1287 |
|
|
2018
Q4 | $1.69M | Buy |
69,988
+63,676
| +1,009% | +$1.5M | ﹤0.01% | 1111 |
|
|
2018
Q3 | $145K | Hold |
6,312
| – | – | ﹤0.01% | 2082 |
|
|
2018
Q2 | $120K | Sell |
6,312
-2,992
| -32% | -$50K | ﹤0.01% | 2136 |
|
|
2018
Q1 | $157K | Hold |
9,304
| – | – | ﹤0.01% | 2026 |
|
|
2017
Q4 | $141K | Buy |
9,304
+6,604
| +245% | +$98K | ﹤0.01% | 2065 |
|
|
2017
Q3 | $48K | Hold |
2,700
| – | – | ﹤0.01% | 2344 |
|
|
2017
Q2 | $44K | Hold |
2,700
| – | – | ﹤0.01% | 2362 |
|
|
2017
Q1 | $38K | Hold |
2,700
| – | – | ﹤0.01% | 2367 |
|
|
2016
Q4 | $43K | Sell |
2,700
-4,800
| -64% | -$77.2K | ﹤0.01% | 2360 |
|
|
2016
Q3 | $125K | Hold |
7,500
| – | – | ﹤0.01% | 2058 |
|
|
2016
Q2 | $84K | Hold |
7,500
| – | – | ﹤0.01% | 2169 |
|
|
2016
Q1 | $63K | Hold |
7,500
| – | – | ﹤0.01% | 2034 |
|
|
2015
Q4 | $70K | Hold |
7,500
| – | – | ﹤0.01% | 1990 |
|
|
2015
Q3 | $85K | Hold |
7,500
| – | – | ﹤0.01% | 1824 |
|
|
2015
Q2 | $95K | Hold |
7,500
| – | – | ﹤0.01% | 1908 |
|
|
2015
Q1 | $69K | Hold |
7,500
| – | – | ﹤0.01% | 1992 |
|
|
2014
Q4 | $107K | Hold |
7,500
| – | – | ﹤0.01% | 1701 |
|
|
2014
Q3 | $78K | Hold |
7,500
| – | – | ﹤0.01% | 1858 |
|
|
2014
Q2 | $121K | Buy |
+7,500
| New | +$99.9K | ﹤0.01% | 1444 |
|
Other funds holding VNDA
Canada Life's VNDA Position: Q4 2023 in Review
Canada Life sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 63,502 shares — an estimated $274K sold.
Canada Life first reported a position in VNDA in Q2 2014 and held it in 37 quarters. The position peaked at $1.69M in Q4 2018. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.
- Canada Life reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Canada Life sold 63,502 Vanda Pharmaceuticals shares in Q4 2023, an estimated $274K.
- Canada Life first reported a position in Vanda Pharmaceuticals in Q2 2014 and held it in 37 quarters.
- Canada Life's Vanda Pharmaceuticals position peaked at $1.69M in Q4 2018.
- 157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.
Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.